Cardiac stimulant activity of Ocimum basilicum Linn. extracts

Indian Journal of Pharmacology

Volumn 36, Issue 3, 2004, Pages 163-166

  Muralidharan, A ^a   Dhananjayan, R ^a  

^a Dr ALM Postgraduate Institute of Basic Medical Sciences   (India)

Author keywords

Adrenergic activity; Cardiotonic; Sweet basil

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); ADENOSINE TRIPHOSPHATASE (MAGNESIUM); ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ADRENALIN; ALANINE AMINOTRANSFERASE; ALCOHOL; ASPARTATE AMINOTRANSFERASE; BETA ADRENERGIC RECEPTOR; CARDIOTONIC AGENT; CREATINE KINASE; DIGOXIN; LACTATE DEHYDROGENASE; NIFEDIPINE; OCIMUM BASILICUM EXTRACT; PROPRANOLOL; WATER;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL TISSUE; AQUEOUS SOLUTION; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BASIL; CHRONOTROPISM; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DISTILLATION; DRUG ACTIVITY; DRUG EFFECT; DRUG SCREENING; ENZYME ACTIVITY; FROG; HEART STIMULATION; INOTROPISM; LACTATE DEHYDROGENASE BLOOD LEVEL; MALE; NONHUMAN; RAT; TISSUE LEVEL;

EID: 2942755982     PISSN: 02537613     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Jain ML, Jain SR. Therapeutic utility of Ocimum basilicum Linn. VAR Album. Planta Med 1988;54:66-70.
2. Dhar AK. Sweet Basil: Ocimum basilicum- a review. Journal of Medicinal and Aromatic Plant Sciences 2002;24:738-55.
3. Warrier PK, Nambiar VPK, Ramankutty C. Indian Medicinal Plants. Orient Longman 1995;3:162-3.
4. Burn JH. Practical pharmacology blackwell. Scientific Publications; 1952. p. 1-7.
5. Okinaka S, Kumagi H, Ebashi S, Sugita H, Momoi H, Toyokura Y, et al. Serum creatine phosphokinase. Activity in progressive muscular dystrophy and neuromuscular diseases. Arch Neurol 1961;4:520-5.
6. King J. The dehydrogenases or oxidoreductases. Lactate dehydrogenase In: Practical Clinical Enzymology. London: Van Nostrand, D.Company Ltd; 1965.
7. King J. The Transferases -alanine and aspartate transaminases In: Practical Clinical Enzymology. London: Van Nostrand, D.Company Ltd; 1965.
8. Bonting SL. Sodium-potassium activated adenosine triphosphatase and cation transport In: Bittar EE, editor. Membrane and ion transport. London: Wiley-Interscience; 1970.
9. 2+ATPase from erythrocyte membranes. Biochem Biophys Acta 1983;728: 281-8.
10. 2+ATPase activities in normal, regenerating and malignant cells. Biochem Biophys Acta 1982;684:67-74.
11. Kitada Y, Narimatsu A, Suzuki R, Endoh M, Taira N. Does the positive ionotropic action of a novel cardiotonic agent, MCI-154, involve mechanisms other than cyclic AMP? J Pharmacol Exp Ther 1987;243:639-45.
12. Beller GA, Smith TW, Abelmann WH, Haber E, Hood WB Jr. Digitalis intoxication. A prospective clinical study with serum level correlations. N Engl J Med 1971;284:989-97.
13. +ATPase in the ionotropic action of digitalis. Pharmacol Rev 1977;29:187-220.
14. Goto A, Yamada K, Yagi N, Yoshioka M, Sugimoto T. Physiology and pharmacology of endogenous digitalis-like factors. Pharmacol Rev 1992;44:377-99.
15. 2+ release channels: a possible role in cardiac ionotropy. Br J Pharmacol 1993;108: 1043-50.
16. 2+ channels and rynodine receptors in heart cells. Nature 2001;410:592-6.
17. Fabiato A. Time and calcium dependence of activation and inactivation of calcium-induced release of calcium from the sarcoplasmic reticulum of a skinned canine cardiac Purkinjee cell. J Gen Physiol 1985;85:247-89.
18. 2+ATPase activities and contractile force. Res Commu Chem Pathol Pharmacol 1992;78:3-16.
19. Kelly RA, Smith TW. Pharmacological treatment of Heart failure. In: Goodman, Gillman, editors. The pharmacological basis of therapeutics. 9th ed. McGraw-Hill; 1996. Chapter 34. p. 811.